The efficacy and safety of tivantinib in the treatment of solid tumors: a systematic review and meta-analysis

BACKGROUND: Tivantinib was designed to kill cancers by targeting the mesenchymal-epithelial transition (MET) protein. Although numerous tivantinib clinical trials are ongoing, tivantinib's efficacy and safety are still not clear. This meta-analysis was done to evaluate tivantinib's efficac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Zhang, Hao, Bao, Zhengqiang, Liao, Hongwei, Li, Wen, Chen, Zhihua, Shen, Huahao, Ying, Songmin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2017
Schlagworte:
Meta-Analysis
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762579/
https://ncbi.nlm.nih.gov/pubmed/29348894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22615
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge